drugset / Trial / NCT03832816

Behavioral and Physiological Effects of THC and CBD

NCT03832816

Phase 1 Withdrawn Johns Hopkins University
RandomizedParallel-groupDouble-blindBasic science

Summary

This study will evaluate physiological and behavioral responses to vaporized delta9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) administered via inhalation.

Timeline

Start
2019-12
Primary completion
2021-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 50 mg Inhaled
Subject Cannabidiol Other / unclassified 100 mg Inhaled
Subject Cannabidiol Other / unclassified 200 mg Inhaled
Subject delta-9-tetrahydrocannabinol Other / unclassified 5 mg Inhaled

Indications

No indication recorded.